Cosmo Pharmaceuticals N.V.
CMOPF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $51 | $44 | $55 | $50 |
| Short-Term Investments | $1 | $99 | $79 | $0 |
| Receivables | $22 | $19 | $24 | $28 |
| Inventory | $12 | $14 | $14 | $14 |
| Other Curr. Assets | $27 | $27 | $13 | $9 |
| Total Curr. Assets | $187 | $202 | $184 | $102 |
| Property Plant & Equip (Net) | $30 | $29 | $27 | $29 |
| Goodwill | $24 | $24 | $24 | $24 |
| Intangibles | $329 | $332 | $374 | $369 |
| Long-Term Investments | $11 | -$67 | $3 | $3 |
| Tax Assets | $0 | $19 | $0 | $17 |
| Other NC Assets | $29 | $108 | $26 | $10 |
| Total NC Assets | $423 | $445 | $455 | $452 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $610 | $647 | $638 | $554 |
| Liabilities | – | – | – | – |
| Payables | $11 | $9 | $15 | $9 |
| Short-Term Debt | $1 | $1 | $1 | $1 |
| Tax Payable | $0 | $21 | $12 | $3 |
| Deferred Revenue | $0 | $0 | $17 | $9 |
| Other Curr. Liab. | $37 | $18 | -$6 | $4 |
| Total Curr. Liab. | $49 | $48 | $38 | $26 |
| LT Debt | $2 | $1 | $1 | $1 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $91 | $0 | $93 |
| Other NC Liab. | $93 | $1 | $94 | $4 |
| Total NC Liab. | $95 | $93 | $95 | $97 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $2 | $2 | $1 | $1 |
| Total Liabilities | $143 | $142 | $133 | $125 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $65 |
| Common Stock | $5 | $5 | $5 | $5 |
| Retained Earnings | $363 | $323 | $374 | $233 |
| AOCI | -$42 | $0 | -$21 | -$23 |
| Other Equity | $135 | $171 | $142 | $142 |
| Total Equity | $460 | $498 | $498 | $422 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $7 | $7 | $7 | $7 |
| Total Liab. & Tot. Equity | $610 | $647 | $638 | $554 |
| Net Debt | -$48 | -$42 | -$53 | -$48 |